Colgate-Palmolive Company (LON:0P59)
| Market Cap | 46.94B |
| Revenue (ttm) | 14.60B |
| Net Income (ttm) | 2.12B |
| Shares Out | n/a |
| EPS (ttm) | 2.60 |
| PE Ratio | 22.11 |
| Forward PE | 20.65 |
| Dividend | 1.57 (2.03%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 6,712 |
| Average Volume | 5,911 |
| Open | 77.00 |
| Previous Close | 77.13 |
| Day's Range | 75.64 - 77.02 |
| 52-Week Range | 75.65 - 100.12 |
| Beta | 0.39 |
| RSI | 38.95 |
| Earnings Date | Oct 31, 2025 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2024, Colgate-Palmolive Company's revenue was $20.10 billion, an increase of 3.31% compared to the previous year's $19.46 billion. Earnings were $2.89 billion, an increase of 25.61%.
Financial numbers in USD Financial StatementsNews
Top stocks to watch today, October 24: Colgate-Palmolive, NTPC Green, Kaynes Tech, Hero MotoCorp, Tata Elxsi and more
Indian stock markets are likely to see stock-specific action on Friday, October 24, as several listed companies have issued fresh...
Colgate stock in focus as Jefferies trims estimates but retains buy on long-term growth prospects
Jefferies has maintained its buy rating on Colgate-Palmolive (India) with a target price of ₹2,700 per share, saying that while...
Nomura cautious on Colgate after 8.5% volume decline, expects modest H2 recovery
Nomura has maintained its reduce rating on Colgate-Palmolive (India) with a target price of ₹2,200 per share after the company...
CLSA neutral on Colgate, notes 6.3% YoY sales decline and slow volume recovery ahead
CLSA has maintained its hold rating on Colgate-Palmolive (India) with a target price of ₹2,130 per share following a weaker-than-expected...
Citi cautious on Colgate after 6% YoY revenue fall, expects revival on easier comps
Citi has maintained its sell rating on Colgate-Palmolive (India) with a target price of ₹2,100 per share after the company...
CL December 5th Options Begin Trading
Investors in Colgate-Palmolive Co. (Symbol: CL) saw new options begin trading today, for the December 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CL opt...
Colgate-Palmolive: 2 Reasons Why The Share Price Drop Has Gone Too Far (Upgrade)
Colgate-Palmolive Webcasts 2025 Third Quarter Earnings Conference Call October 31, 2025 – 8:30 a.m. ET
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 third quarter earnings conference call on Friday, October 31, 2025, at 8:30 a.m. ET. The call wil...
Raymond James Adjusts Price Target for Colgate-Palmolive (CL) Amidst Maintaining Rating | CL ...
Raymond James Adjusts Price Target for Colgate-Palmolive (CL) Amidst Maintaining Rating | CL Stock News
Colgate Stock Is an Antidote to AI-Dominated Markets. Why Its Worth Buying Now.
Friday's ETF Movers: KXI, SIL
In trading on Friday, the iShares Global Consumer Staples ETF is outperforming other ETFs, up about 1.3% on the day. Components of that ETF showing particular strength include shares of Kenvue, up abo...
Colgate-Palmolive falls to a 22-month low as earnings approach
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) to $88 | CL Stock News
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) to $88 | CL Stock News
Colgate-Palmolive (CL) Rating Maintained, Price Target Lowered to $88 | CL Stock News
Colgate-Palmolive (CL) Rating Maintained, Price Target Lowered to $88 | CL Stock News
UBS Lowers Colgate-Palmolive (CL) Price Target to $92 | CL Stock News
UBS Lowers Colgate-Palmolive (CL) Price Target to $92 | CL Stock News
Oversold Conditions For Colgate-Palmolive
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a tec...
10 Defensive Stocks To Consider Buying As Experts Get Skittish
Economic risks are piling up, and investors are starting to wonder whether shifting their focus to capital preservation is a good idea right now.
Colgate-Palmolive (CL) Sees Neutral Rating from Piper Sandler | CL Stock News
Colgate-Palmolive (CL) Sees Neutral Rating from Piper Sandler | CL Stock News
Goldman Sachs Lowers Price Target for Colgate-Palmolive (CL) Amidst Buy Rating | CL Stock News
Goldman Sachs Lowers Price Target for Colgate-Palmolive (CL) Amidst Buy Rating | CL Stock News
Calls of the Day: Colgate and BlackRock
CNBC's “Halftime Report” team break down some of their recent stock action and the calls of the day.
Calls of the Day: Colgate and BlackRock
CNBCs Halftime Report team break down some of their recent stock action and the calls of the day.
Colgate-Palmolive (CL) Analyst Update: Barclays Lowers Price Target | CL Stock News
Colgate-Palmolive (CL) Analyst Update: Barclays Lowers Price Target | CL Stock News
CL Quantitative Stock Analysis - Warren Buffett
Below is Validea's guru fundamental report for COLGATE-PALMOLIVE CO (CL). Of the 22 guru strategies we follow, CL rates highest using our Patient Investor model based on the published strategy of Warr...
Colgate Women's Games Officially Kicks Off and Introduces Refreshed Logo For Milestone 50th Season
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company announced today that Colgate Women's Games (CWG), the nation's longest-running indoor track and field series for girls and women, has officially ki...
Best Dividend Aristocrats For October 2025
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc...